Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Human cerebrospinal fluid peptidomics.

Xianglin Yuan1, Dominic M Desiderio

  • 1Charles B. Stout Neuroscience Mass Spectrometry Laboratory, University of Tennessee Health Science Center, 847 Monroe Avenue, Memphis, Tennessee 38163, USA.

Journal of Mass Spectrometry : JMS
|February 12, 2005
PubMed
Summary

Peptidomics analysis of cerebrospinal fluid (CSF) reveals peptides from proteins linked to central nervous system (CNS) disorders. This method offers a comprehensive approach to understanding CNS disease mechanisms and identifying potential biomarkers.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

CXCL11 recruits immunosuppressive cells to form a barrier at the invasive front of pancreatic cancer by activating the NF-κB/CCL2 axis.

Translational oncology·2026
Same author

Interpretable early mortality prediction in oncology ICU patients: A dual-cohort validation of a LASSO-XGBoost-SHAP framework.

Digital health·2026
Same author

HDAC inhibitors reverse YAP-driven immune resistance in NSCLC: mechanistic and translational evidence.

Journal for immunotherapy of cancer·2026
Same author

An inhalable nanozyme for STING blockade to treat radiation-induced lung injury.

Journal of nanobiotechnology·2026
Same author

Total-Body Dynamic PET/CT Imaging of Proton-Induced Activity and Biologic Washout After Proton Therapy.

Journal of nuclear medicine : official publication, Society of Nuclear Medicine·2026
Same author

Real-World Treatment Patterns, HER2 Testing Practices, and Clinical Outcomes in HER2-Positive Locally Advanced or Metastatic Gastric or Gastroesophageal Junction Cancer.

Advances in therapy·2026

Area of Science:

  • Neuroscience
  • Biochemistry
  • Analytical Chemistry

Background:

  • Cerebrospinal fluid (CSF) is crucial for studying central nervous system (CNS) disorders due to its content of regulatory molecules.
  • Previous studies focused on individual neuropeptidergic systems in CSF.
  • Peptidomics provides a comprehensive, systems-level analysis of all expressed peptidergic systems in CSF.

Purpose of the Study:

  • To establish and validate a peptidomics approach for analyzing low molecular mass peptides in human lumbar CSF.
  • To identify peptides in CSF and their protein origins, particularly those associated with CNS disorders.
  • To lay the groundwork for monitoring peptide changes and discovering biomarkers for CNS diseases.

Main Methods:

  • Isolation of low molecular mass peptides (< 5 kDa) from CSF via ultrafiltration.

Related Experiment Videos

  • Enrichment of peptides using solid-phase extraction, with and without trypsin digestion.
  • Separation by capillary liquid chromatography and analysis by on-line quadrupole time-of-flight mass spectrometry (MS).

    • Main Results:

    • Successfully characterized 20 representative peptides using MS.
    • These peptides were identified as originating from 12 distinct proteins.
    • Four identified proteins (amyloid-like protein 1, secretogranin I, granin-like neuroendocrine peptide precursor, neurosecretory protein VGF) are known to be associated with CNS disorders or play key CNS roles.

    Conclusions:

    • The developed analytical method is effective for analyzing the human lumbar CSF peptidome.
    • This peptidomics approach can monitor CSF peptide changes and modifications.
    • The study provides a foundation for elucidating CNS disorder mechanisms and identifying novel biomarkers.